Source: UNIPROT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TATA-box binding protein associated factor 1 like | 0.839 | 0.154 | 0.96 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
kelch like ECH associated protein 1 | 0.475 | 0.808 | 3.9E-04 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2015 | 2020 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.380 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
casein kinase 1 epsilon | 0.619 | 0.615 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
EPH receptor A3 | 0.497 | 0.692 | 1.2E-05 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2012 | 2015 | ||||||||
|
EPH receptor A8 | 0.686 | 0.346 | 1.8E-10 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.650 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.440 | None | 0.833 | 0 | 0 | 2008 | 2019 | ||||||||
|
polo like kinase 2 | 0.575 | 0.808 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2005 | 2013 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
ribosomal protein S6 kinase A6 | 0.686 | 0.385 | 0.99 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
tyrosine kinase non receptor 2 | 0.623 | 0.538 | 8.2E-12 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2014 | 2017 | ||||||||
|
serum/glucocorticoid regulated kinase 2 | 0.780 | 0.192 | 2.2E-12 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ribosomal protein S6 kinase C1 | 0.821 | 0.231 | 1.3E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
protein kinase D2 | 0.666 | 0.538 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
large tumor suppressor kinase 2 | 0.554 | 0.654 | 0.99 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2014 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 6 | 0.656 | 0.538 | 2.7E-10 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
protein serine kinase H2 | 0.890 | 0.077 | 7.2E-09 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.330 | None | 1.000 | 0 | 1 | 2004 | 2014 | ||||||||
|
large tumor suppressor kinase 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
Fas activated serine/threonine kinase | 0.617 | 0.615 | 4.7E-03 |
|
disease | 0.310 | None | 1.000 | 0 | 1 | 2016 | 2016 | ||||||||
|
myosin XVIIIB | 0.628 | 0.615 | 1.0E-31 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
protein kinase, DNA-activated, catalytic subunit | 0.540 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 1 | 2015 | 2015 | ||||||||
|
endoplasmic reticulum to nucleus signaling 1 | 0.513 | 0.808 | 0.99 |
|
disease | 0.310 | None | 1.000 | 0 | 1 | 2017 | 2017 |